Graduated in Pharmacy-Biochemistry (2013) from the School of Pharmaceutical Sciences, University of São Paulo (FCF-USP). Holds a Masters degree (2015) from the Graduate Program in Pharmacy (Clinical Analysis) and a Ph.D. (2019) from the Graduate Program in Pharmacy (Pathophysiology and Toxicology), Department of Clinical and Toxicological Analysis, FCF-USP, conducting basic research in the field of Hematology, with emphasis on folic acid and B-complex vitamin metabolism and myeloproliferative neoplasms. Worked as Assistant Professor I at Universidade Cidade de São Paulo, being part of Pharmacy (Bachelors) program and teaching in Pharmacy, Biomedicine, and Physiotherapy undergraduate courses. Currently working as Assistant Professor A, Level 1, in the Department of Pathology (MPT) at the Faculty of Medicine (CMM) of the Fluminense Federal University (UFF). Experience in teaching Clinical and Laboratory Hematology and involved in research projects focusing on (1) folate and vitamin B12 metabolism; (2) investigation of genetic polymorphisms associated with thrombophilias; and (3) the identification of new biomarkers in sickle cell disease. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Myelofibrosis (MF) is a Myeloproliferative Neoplasm (MPN) Philadelphia negative characterized by fibrosis development in bone marrow, in response to cell proliferation. Discover of JAK2V617F mutation and its relation with MF made possible the development of drugs targeted to the inhibition of JAK2 protein. However, little information is known about the mechanisms involved in inhibitors of…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID